How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study

Morgane Guillou Landreat (1, 2) , Antoine Dany (2) , Gaelle Challet Bouju (1, 3) , Edouard-Jules Laforgue (1, 3) , Jennifer Cholet (3) , Juliette Leboucher (3) , Jean-Benoit Hardouin (1) , Pierre Bodenez , Bertrand Le Geay , Isabelle Martineau , Philippe Levassor , Paul Bolo , Jean-Yves Guillet , Xavier Guillery , Corine Dano , Caroline Victorri Vigneau (1, 4) , Marie Grall Bronnec (1, 3)

1 SPHERE - MethodS in Patients-centered outcomes and HEalth ResEarch
2 EA7479 SPURBO - Soins Primaires, Santé Publique, Registre des cancers de Bretagne Occidentale
3 Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000 Nantes, France
4 Service de Pharmacologie Clinique [CHU Nantes]

Abstract Background The resurgence of heroin use and the misuse of pharmaceutical opioids are some of the reasons for a worldwide increase in opioid dependence. Opioid Medication Therapies (OMT) have amply demonstrated their efficacy. From a medical point of view, the main objectives of OMT concern medical and social outcomes, centred on risk reduction and the cessation of opioid use. But patient points of view can differ and few studies have explored opioid-dependent patient viewpoints on their OMT. This variable seems important to consider in a patient-centred approach. The aim of our study was to explore points of view of people who use drugs (PWUD) treated with OMT, in a large multicentre sample. Method A cross-sectional multicentre study explored the points of view of PWUD with Opioid Use Disorder following OMT. Data regarding the patients’ points of view were collected using a self-administered questionnaire developed by the scientific committee of the study. A descriptive analysis and an exploratory factor analysis were performed to explore the structure of items exploring patient viewpoints. Results 263 opioid dependent PWUD were included, a majority were men consuming heroin prior to being prescribed OMT. 68% were on methadone, 32% were on buprenorphine. Most PWUD identified a positive impact on their lives, with 92.8% agreeing or strongly agreeing that OMT had changed a lot of things in their lives. The exploratory factor analysis identified three factors: (F1) items related to points of views concerning the objectives and efficacy of OMT; (F2) items related to the legitimacy of OMT as a treatment compared to a drug, (F3) items related to experiences and relationships with OMT. Conclusion Patient viewpoints on efficacy were correlated with the pharmacological benefits of OMT and with the associated psychosocial measures. The implications of OMT in relationships, such as the feeling of being judged, concerned a majority. Points of view were ambivalent concerning the role of OMT as a treatment or as a drug. Involving patient points of view in therapeutic strategies decisions could help enhance positive views among PWUD on OMT and help PWUD towards their recovery. Trial registration: OPAL study was registered: (NCT01847729).

Domaines: Sciences du Vivant [q-bio]; Psychologie et comportements

Morgane Guillou Landreat, Antoine Dany, Gaelle Challet Bouju, Edouard-Jules Laforgue, Jennifer Cholet, et al.. How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study. Harm Reduction Journal, 2022, 19, ⟨10.1186/s12954-022-00608-6⟩. ⟨hal-03629554⟩